Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Acq. announced Asset disposition
|
CLINICAL DATA INC (CLDA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/02/2011 |
BW
| The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA |
03/02/2011 |
BW
| Brower Piven Announces an Investigation of the Acquisition of Clinical Data, Inc. by Forest Laboratories, Inc. |
02/25/2011 |
BW
| Goldman Scarlato & Karon, P.C. Announces Investigation of Clinical Data, Inc. |
02/25/2011 |
BW
| Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Clinical Data, Inc. |
02/23/2011 |
BW
| Clinical Data, Inc. Shareholder Investigation by Briscoe Law Firm Concerning Acquisition by Forest Laboratories, Inc. |
02/23/2011 |
BW
| Ryan & Maniskas, LLP Announces Investigation of Clinical Data, Inc. |
02/22/2011 |
BW
| The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA |
02/22/2011 |
BW
| Robbins Umeda LLP Is Investigating Clinical Data, Inc. Acquisition for Shareholders |
02/22/2011 |
BW
| Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Clinical Data, Inc. - CLDA |
02/22/2011 |
BW
| Finkelstein Thompson LLP Announces Investigation of Clinical Data, Inc. |
02/22/2011 |
BW
| Kendall Law Group Investigates Clinical Data, Inc. for Shareholders |
02/22/2011 |
BW
| Rigrodsky & Long, P.A. Investigates Buyout of Clinical Data, Inc. - CLDA |
02/22/2011 |
BW
| Harwood Feffer LLP Announces Investigation of Clinical Data, Inc. |
02/22/2011 |
BW
| The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA |
12/08/2010 |
BW
| Clinical Data, Inc. Announces Vilazodone Data Presented at American Society of Health System Pharmacists |
12/08/2010 |
BW
| Clinical Data, Inc. to Present at Deutsche Bank's 2010 BioFEST |
11/29/2010 |
BW
| Clinical Data, Inc. to Sell FAMILION® Testing and Pharmacogenomics Biomarker Development Business for $15.4 Million Plus Potential Milestones, Royalties and other Consideration |
11/23/2010 |
BW
| Clinical Data, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference |
11/22/2010 |
BW
| Clinical Data, Inc. Announces Vilazodone Data Featured at the 2010 U.S. Psychiatric & Mental Health Congress |
11/15/2010 |
BW
| Clinical Data, Inc. Files Shelf Registration Statement |
11/09/2010 |
BW
| Clinical Data, Inc. Reports Second Quarter Fiscal Year 2011 Operational and Financial Results |
11/08/2010 |
BW
| Clinical Data, Inc. Launches FAMILION® Genetic Tests for Left Ventricular Noncompaction and Long QT Syndrome Large Deletion/Duplication Mutations |
11/05/2010 |
BW
| Clinical Data, Inc. Receives Therapeutic Discovery Project Grants |
11/01/2010 |
BW
| Clinical Data, Inc. Granted Orphan Drug Designation for PRX-8066 for Pulmonary Arterial Hypertension |
10/14/2010 |
BW
| Clinical Data, Inc. to Present at the Newsmakers in the Biotech Industry Conference |
10/04/2010 |
BW
| Clinical Data, Inc. Launches FAMILION® Genetic Test for Medical Examiners to Aid in Determining the Cause of Sudden Unexplained Death and Sudden Infant Death Syndrome |
09/24/2010 |
BW
| Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze™ Demonstrating Safety and Tolerability in Patients with Asthma and COPD |
09/21/2010 |
BW
| Clinical Data, Inc. to Present at the JMP Securities Healthcare Conference |
08/09/2010 |
BW
| Clinical Data, Inc. Reports First Quarter Fiscal Year 2011 Operational and Financial Results |
07/29/2010 |
BW
| Clinical Data, Inc. to Present at Upcoming Investor Conferences |
06/14/2010 |
BW
| Clinical Data, Inc. Announces Closing of $32.0 Million Public Offering Including Full Exercise of Over-Allotment |
06/14/2010 |
BW
| Clinical Data, Inc. Reports Fourth Quarter and Fiscal Year 2010 Results |
06/09/2010 |
BW
| Clinical Data, Inc. Prices Public Offering of Common Stock |
06/08/2010 |
BW
| Clinical Data, Inc. Announces Public Offering of Common Stock |
|
|
|